Cleared Traditional

K260063 - GSPE Spacer

K260063 is an FDA 510(k) clearance for GSPE Spacer, manufactured by The General Hospital Corporation, d/b/a Massachusetts. The device is a Class 2 Orthopedic device with product code JWH cleared through the Traditional 510(k) pathway after a 246-day FDA review.

K260063 · The General Hospital Corporation, d/b/a Massachusetts · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2026
Decision
246d
Days
Class 2
Risk

K260063 is an FDA 510(k) clearance for the GSPE Spacer. Classified as Prosthesis, Knee, Patellofemorotibial, Semi-constrained, Cemented, Polymer/metal/polymer (product code JWH), Class II - Special Controls.

Submitted by The General Hospital Corporation, d/b/a Massachusetts (Somerville, US). The FDA issued a Cleared decision on September 11, 2026 after a review of 246 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3560 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all The General Hospital Corporation, d/b/a Massachusetts devices

FDA 510(k) Submission Details - K260063

510(k) Number K260063 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 08, 2026
Decision Date September 11, 2026
Days to Decision 246 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
PCCP Authorized No
Regulatory Context
Review time vs. panel average
124d slower than avg
Panel avg: 122d · This submission: 246d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JWH Device Classification - Class 2, Special Controls

Product Code JWH Prosthesis, Knee, Patellofemorotibial, Semi-constrained, Cemented, Polymer/metal/polymer
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Mcra, LLC
Hollace Rhodes

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - JWH Prosthesis, Knee, Patellofemorotibial, Semi-constrained, Cemented, Polymer/metal/polymer

All 908
Devices cleared under the same product code (JWH) and FDA review panel - the closest regulatory comparables to K260063.
GMK Extension
K262057 · Medacta International, SA · Sep 2026
EVOLUTION MPX™ Total Knee System
K262293 · Suzhou Microport Orthorecon Co., Ltd. · Sep 2026
b-ONE® Mobio™ Total Knee System Revision Cemented Tibial Augments, Stem Extensions and Press-Fit Stem Extensions
K262341 · B-One Ortho, Corp. · Sep 2026
ATTUNE Revision Knee System
K262130 · DePuy Orthopaedics, Inc. · Sep 2026
SK Knee System
K253961 · Just Medical Devices (Tianjin) Co., Ltd. · Sep 2026
Freedom Total Knee System (E-Poly Tibial Liners)
K261563 · Maxx Orthopedics, Inc. · Aug 2026